Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma

K. Thompson-Wicking; R.W. Francis; A. Stirnweiss; E. Ferrari; M.D. Welch; E. Baker; Ashleigh Murch; Alexander Gout; Kim Carter; A.K. Charles; M.B. Phillips; Ursula Kees; Alex Beesley

doi:10.1038/onc.2012.487

Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma

K. Thompson-Wicking, R.W. Francis, A. Stirnweiss, E. Ferrari, M.D. Welch, E. Baker, Ashleigh Murch, Alexander Gout, Kim Carter, A.K. Charles, M.B. Phillips, Ursula Kees, Alex Beesley

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	4664-4674
Journal	Oncogene
Volume	32
Issue number	39
DOIs	https://doi.org/10.1038/onc.2012.487
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/onc.2012.487

Cite this

@article{ffdf160389b0404980ab3f7a36bc8614,

title = "Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma",

author = "K. Thompson-Wicking and R.W. Francis and A. Stirnweiss and E. Ferrari and M.D. Welch and E. Baker and Ashleigh Murch and Alexander Gout and Kim Carter and A.K. Charles and M.B. Phillips and Ursula Kees and Alex Beesley",

year = "2013",

doi = "10.1038/onc.2012.487",

language = "English",

volume = "32",

pages = "4664--4674",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "39",

}

TY - JOUR

T1 - Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma

AU - Thompson-Wicking, K.

AU - Francis, R.W.

AU - Stirnweiss, A.

AU - Ferrari, E.

AU - Welch, M.D.

AU - Baker, E.

AU - Murch, Ashleigh

AU - Gout, Alexander

AU - Carter, Kim

AU - Charles, A.K.

AU - Phillips, M.B.

AU - Kees, Ursula

AU - Beesley, Alex

PY - 2013

Y1 - 2013

U2 - 10.1038/onc.2012.487

DO - 10.1038/onc.2012.487

M3 - Article

C2 - 23128391

VL - 32

SP - 4664

EP - 4674

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 39

ER -